Home / Negeri Sembilan / Vaccine Plant
#21764
NINEBIO SDN BHD (9BIO) - ENSTEK HALAL VACCINE PLANT
Preview

Overview: NINEBIO SDN BHD (9BIO) - ENSTEK HALAL VACCINE PLANT is a Vaccine Plant construction project in Negeri Sembilan. NINEBIO SDN BHD is currently recorded at Cancelled. The project value is recorded in the More than 1 billion range. myBina has identified 2 companies across 2 roles on NINEBIO SDN BHD: 1 developer and 1 contractor. This record was last verified on 24 April 2012 (Issue 201204.3).

State
Negeri Sembilan
Status
Cancelled
Ownership
Private
Value Range
More than 1 billion
Project Information  Preview
Project ID:21764
Issue Number:201204.3
Project Status: Cancelled
State:Negeri Sembilan
Category:Vaccine Plant
Full Address:
Construction Start:
Target Completion:
Project Ownership:Private
Value Range:More than 1 billion
Project Value:
Contractor Spec:
Tender Deadline:
Project Details  Locked

Full project details are on record for NINEBIO SDN BHD (9BIO) - ENSTEK HALAL VACCINE PLANT, covering the scope of works, site arrangement and contract structure. Available to myBina subscribers.

Specifications  Locked

Recorded specifications for this project cover structural, M&E and finishes requirements, alongside contractor grade and tender details. Available to myBina subscribers.

Companies Identified 2 companies · 2 roles

myBina has identified 2 companies across 2 roles on NINEBIO SDN BHD (9BIO) - ENSTEK HALAL VACCINE PLANT: 1 developer and 1 contractor.

Developer
1 co.
1 company identified, name and contact available to subscribers.
Contractor
1 co.
1 company identified, name and contact available to subscribers.

 Contact us to reveal company names, phone numbers, emails and full contact details.

Similar Projects Vaccine Plant · Negeri Sembilan

Other Vaccine Plant construction projects recorded by myBina in Negeri Sembilan:

Need access to all 10,000+ projects?

A myBina membership gives you unlimited access across all states, categories and project statuses — with alerts, CRM tools and export features.

Contact Us